CARCINOMA OF
PARANASAL SINUSES
Epidemiology
• Maxillary sinus ca – 70%
• Ethmoid(20%),frontal(3%),sphenoid(1%)
sinus ca – extremely rare
• 3% of head and neck malignacies
• M > F ( 2 : 1 )
• Age – 6th
& 7th
decades
• Carpenters, saw mill workers
• Occupational exposure
• Smoking
• Alcohol
Occupational agents correlated with
sinonasal cancer
Epithelial epidermoid Squamous cell carcinoma (spindlecell, verrucous, transitional
Epithelial non-
epidermoid
Adenoid cystic carcinoma, Adenocarcinoma
Mucoepidermoid carcinoma
Acinic cell carcinoma
neuroectodermal tumour Malignant melanoma, Olfactory neuroblastoma
Neuroendocrine carcinoma
Sinonasal undifferentiated carcinoma, Ewing’s sarcoma
Odontogenic tumours Ameloblastoma
Mesenchymal Fibrosarcoma, Liposarcoma
Malignant fibrous histiocytoma
Alveolar soft-part sarcoma
Muscular Leiomyosarcoma, Rhabdomyosarcoma
Vascular Angiosarcoma, Kaposi’s sarcoma
Glomangiopericytoma (haemangiopericytoma)
Cartilaginous Chondrosarcoma (mesenchymal)
Osseous osteosarcoma
Lymphoreticular Non-Hodgkin’s lymphoma, Burkitt’s lymphoma
Extramedullary plasmacytoma
T/NK lymphoma, Histiocytic/dendritic cell
malignancies
Squamous cell carcinoma
• Squamous cell carcinoma remains the most
common sinonasal malignancy
• The majority probably arise in the maxillary sinus
• Rarely the nasal septum or columella are the
primary site.
• These tumours have a particularly poor
prognosis due to the possibility of bilateral
metastatic spread to cervical nodes.
ADENOCARCINOMA
• Aout 30 per cent of patients with this condition
are woodworkers.
• These tumours usually arise in the middle meatus
and spread into the ethmoid
• Adenocarcinoma is generally rather radioresistant
but combined therapy is usually offered.
• Many patients require a craniofacial but in
selected cases have been treated successfully by
an endoscopic resection.
Adenoid cystic carcinoma
• Propensity to spread along perineural
lymphatics which compromises attempts at
excision.
• known to produce blood-borne metastases,
classically to the lung while lymphatic spread
is rare.
• Treatment is generally combined surgery and
radiotherapy
OLFACTORY NEUROBLASTOMA (OR)
ESTHESIONEUROBLASTOMA
• classically arises from olfactory epithelium in the upper nasal
vault
• The presence of a mass in the upper nasal cavity with
associated skull base erosion is typical.
• bimodal peak in the second/third and sixth/seventh decades.
• Cervical metastases have been described in up to 23%.
• These are routinely resected in craniofacial approaches
• Endoscopic resection is being increasingly offered for this
tumour particularly when it arises from the middle and
superior turbinates.
• should always be combined with radiotherapy.
Ohngren's Line
· Line running from
medial canthus to
angle of mandible
· Prognosis of
suprastructure
tumors worse (This
was before advent of
craniofacial
resection)
Natural history & spread
Maxillary ca
Natural history & spread - contd
Ethmoidal ca
Natural history & spread – contd…
Sphenoid sinus ca Frontal sinus ca
Lymphatic Drainage
• Usually sparse-10% incidence of cervical LNE
• If tumor extension into skin of face, nasal
cavity, NPX -> ↑ed incidence of LN->Assocated
with poor prognosis
• First echelon: submandibular nodes
• Second echelon: subdigastric nodes - same
side
• Contralateral mets. extremely rare
Clinical features
Maxillary sinus ca
• Facial swelling, pain, paresthesia of cheek
• Epistaxis, nasal discharge, obstruction
• Ill fitting dentures, alveolar/palatal mass
• Proptosis, diplopia, impaired vision, orbital pain
Ethmoid sinus ca
• Headache
• Referred pain to nasal, retrobulbar region
• SC mass at inner canthus, nasal
obstruction,discharge, diplopia & proptosis
Work up
• H & P
• Routine blood examination
• CXR- Adenocystic ca
• CT/MRI
• Dental evaluation
• Baseline ophthalmologic examn
• Baseline speech & swallowing assessment
• Fiberoptic endoscopic examination & Bx
Computed Tomography
• Bone erosion
– orbit, cribiform plate
– fovea, post max sinus wall
– sphenoid, post wall of
frontal sinus
• 85% accuracy
• ? Tumor vs. inflammation vs.
secretions
• Limitation-periorbital
involvement
• CT Chest for Adenocystic ca
MRI
• Superior to CT
- multiplanar
- Detect intracranial,
perineural & leptomeningeal
spread
• Inflammatory tissue &
secretions - intense T2
• Tumor - intermediate T1 &
T2 (low signal)
• 94% accuracy
• gadolinium (enhancement)
98% accuracy
Primary tumor (T)
Maxillary sinus:
TX Primarytumorcannotbe assessed
T0 No evidence ofprimarytumor
Tis Carcinoma insitu
T1 Tumor limited to maxillarysinus mucosa with noerosionordestructionofbone
T2
Tumor causingbone erosionordestruction, includingextension into the hard palate and/or middlenasalmeatus, exceptextension to posteriorwallofthe
maxillarysinus and pterygoidplates
T3
Tumor invades anyofthe following:bone ofthe posteriorwallofthe maxillarysinus, subcutaneous tissues, flooror medial wallofthe orbit, pterygoid fossa,
ethmoidsinuses
T4a
Moderatelyadvanced localdisease
 Tumor invades theanteriororbitalcontents, skinofthe cheek, pterygoid plates, infratemporalfossa, cribriformplate, sphenoidorfrontalsinuses
T4b
Veryadvanced localdisease
 Tumor invades anyofthe following: orbitalapex, dura, brain, middle cranialfossa, cranial nerves otherthan maxillarydivisionoftrigeminalnerve (V2),
nasopharynx, orclivus
AJCC- Nasal cavity & Ethmoid Sinus
Tx - Primary tm cannot be assessed
To - no evidence of primary tm
Tis - carcinoma in situ
T1 - Tm restricted to any one subsite with or without bony
invasion
T2 - invading two subsite in a single region or extending to
involve an adjacent region within the nasoethmoidal complex
T3 - invade medial wall/ floor of orbit, maxillary sinus,palate/
cribiform plate
T4a - invade ant orbital contents, skin of nose /cheek, ant cranial
fossa, pterygoid plates,sphenoid/ frontal sinus
T4b - orbital apex, dura, brain,mid cranial fossa, cr nerves,
nasopharynx/ clivus
Staging – contd…
Nx - regional nodal status cannot be assessed,
No - No regional lymph node metastasis
N1 - single I/L clinically +ve lymph node ≤ 3cm
N2 - metastasis in ipsilateral, bilateral, contralateral node
N2a - single I/L +ve LN >3cm <6cm
N2b - multiple, I/L +ve LN <6cm
N2c - B/L or C/L LN <6cm
N3 - any LN > 6cm
Mx - distant metastasis cannot be assessed
Mo - No distant metastasis
M1 -distant metastasis
Staging – contd…
Stagewise distribution
stage I - T1N0M0
stage II – T2N0M0
stage III – T3N0M0 OR T1-T3N1M0
stage IV :
- IVA -T4N0-1M0
any TN2 M0
- IVB any TN3M0
- IVC any T any N, M1
Treatment options
Maxillary sinus ca
• Surgery
• Radiotherapy
- definitive
- pre op RT
- post op RT
• Combined modality ( Sx + RT)
• Chemotherapy
- Neo adjuvant
- Concomitant
Stagewise Treatment
Stagewise Treatment – contd…
Surgery
Contraindications
- extension thr ant. Fossa
- involvement of both optic n.
- post. extension into sphenoid sinus
- invasion of middle cranial fossa
- extension into NPx
- inoperable neck node & distant mets
• CRANIOFACIAL RESECTION
• MIDFACIAL DEGLOVING
• LATERAL RHINOTOMY
• MAXILLECTOMY
• ENDOSCOPIC RESECTION
• TOTAL RHINECTOMY
Craniofacial resection
• the ‘gold standard’ for tumours affecting the anterior skull
base.
CONTRAINDICATIONS
• Extensive frontal lobe and/or middle cranial fossa
involvement or bilateral orbital invasion/optic chiasm.
• Certain histologies, such as mucosal malignant melanoma
where extent of surgery does not influence outcome
• those where surgery is not appropriate, such as sinonasal
undifferentiated carcinoma, lymphoma, plasmacytoma.
• Distant metastasis.
INCISION
• Following bilateral temporary tarsorrhaphies,
an extended lateral rhinotomy is made on the
side of maximal tumour involvement
TECHNIQUE
• The soft tissues of the face are mobilized by subperiostial
elevation to expose the nasal bones, frontal processes of the
maxilla and frontal bone up to the hairline via an extended lateral
rhinotomy.
• Through the lateral rhinotomy, the upper lateral cartilage is
separated from the nasal bone to allow complete retraction of the
nasal ala.
• The orbital periosteum is elevated to expose the lacrimal fossa
and the medial orbital wall. The nasolacrimal duct is often
transacted obliquely at this point
• anterior and posterior ethmoidal arteries are divided after bipolar
coagulation.
• If the lamina has been eroded by tumour, the adjacent periorbita
should be resected for frozen section assessment
• A shield-shaped craniotomy is performed above the level of
the supraorbital rim to include the frontal sinus. usually
approximately 3x3x3.5 cm size.
• The frontal sinus which has been opened by this manoeuvre
is cleared of its mucosa and the posterior wall removed
combined with a wide dissection of the dura.
• Dissection around the cribriform plate and crista galli is
facilitated by the use of the operating microscope.
• This dissection continues until the cribriform plate is
exposed and continues on to the jugum of the sphenoid.
• In cases of olfactory neuroblastoma routinely the olfactory
bulb and tracts are removed in continuity.
• The anterior and posterior ethmoidal arteries are coagulated
with the bipolar diathermy although care must be exercised
as the optic nerve is approached.
2b. malignant nasal paranasal sinus ca.pptx
2b. malignant nasal paranasal sinus ca.pptx
• Osteotomies are performed around the cribriform plate
through the ethmoidal and sphenoid roofs.
• The posterior osteotomy crosses the planum sphenoidale to
include the anterior face of the sphenoid and the nasal
septum is separated by quadrilateral cuts.
• The specimen is mobilized this can be removed, haemostasis
achieved and the cavity inspected for further resection.
• fashion a large middle meatal antrostomy to prevent
subsequent infection.
• dura has small defects which can be repaired primarily but
more with fascia lata held in place with fibrin glue to which a
split-skin graft taken from the thigh is applied inferiorly.
• The frontal bone flap is replaced and secured with miniplates.
• The periosteum and subcutaneous layer is closed with
absorbable sutures and skin with clips or fine skin sutures. A
pressure dressing is applied to both the head and leg.
POST OP CARE
• Patients are kept in a neutral position of
approximately 15 degree for the first 2 or 3
days and then gently elevated.
• The urinary catheter is removed on the second
or third day and facial sutures after 5–7 days.
• The anticonvulsant is continued for 6 weeks
following the operation and patients must
douche the nose long term.
• Complications are:
• IMMEDIATE:
• – convulsions
• – haemorrhage
• – air embolism
• INTERMEDIATE:
• – cerebrovascular accident
• – confusion
• – pulmonary embolism
• – meningitis
• – aerocele
• LONG TERM:
• – haemorrhage
• – frontal abscess/encephalitis
• – bone necrosis/fistula
• – cerebrospinal fluid leak
• – epilepsy
• – epiphora
• – diplopia
• – serous otitis media
• – sinusitis/mucocele
• – cellulitis
• – pituitary deficiency
MIDFACIAL DEGLOVING
• The degloving approach affords excellent access to the middle third of the face.
• Indicated in malignant tumours affecting the nasal
cavity,maxilla,ethmoids,sphenoid, pterygopalatine and infratemporal fossae.
INCISION
• After temporary tarrsoraphies, a bilateral sublabial incision is made from
maxillary tuberosity to tuberosity down to bone
• Routine rhinoplasty intercartilaginous incisions are made extending into a
transfixion incision along the dorsal and caudal borders of the cartilaginous
septum,separating it from the medial crura of the lower lateral cartilages.
• The circumferential incisions are joined across the floor of the nose just
anterior to the pryriform aperture.
2b. malignant nasal paranasal sinus ca.pptx
• The soft tissues of the midface are elevated
subperiosteally up to the infraorbital nerve on each side
to display the pyriform aperture.
• The soft tissues over the nasal bridge are elevated as far
as the root of the nose and laterally to complete the
mobilization from below so that the mid-third of the face
is completely elevated and can be lifted superiorly over
the nasal skeleton.
• nasal cavities and maxillary sinuses can be opened using
drills, hammers and osteotomes.
• maxillary and sphenopalatine arteries accessed and
ligated
2b. malignant nasal paranasal sinus ca.pptx
2b. malignant nasal paranasal sinus ca.pptx
• ethmoids, sphenoid, nasopharynx and structures
posterior and lateral to the maxillae are reached for
further resection.
• Closure of the incisions must be done with care to
avoid complications, using absorbable suture material.
• The bridge of the nose may be taped or a rhinoplasty
dressing applied for a few days.
• After pack removal patients advised to use saline
douching daily until crusting settles.
Lateral rhinotomy
• Indicated in any malignant tumour affecting the
nasal septum,lateral wall and extending into
ethmoid, sphenoid, maxillary sinuses and up to the
anterior skull base
INCISION
• After a temporary tarrsoraphy, the incision runs from
the level of the medial canthus, midway between the
canthus and nasal bridge in the nasomaxillary
groove, curving round the lower ala into the nasal
cavity
TECHNIQUE
• Through the incision, the orbital periosteum can be dissected
from the lamina and the nasolacrimal duct mobilized.The
duct can be transected obliquely adjacent to the sac.
• Anterior and posterior ethmoidal arteries ligated
• An en bloc or piecemeal removal of lateral nasal wall done
including the pyriform aperture,nasal bone,frontal process of
maxilla,anterior maxillary wall,medial orbital wall and
rim,ethmoids lamina pipyracea and lacrymal fossa depending
upon extend of tumour.
• The sphenoid sinus can be opened,frontal can be
accesed,orbital periosteum can be resected if required
MAXILLECTOMY
• Malignant tumors of maxilla involving all walls with/without orbital
extension.
INCISION
-Weber-Fergusson incision extends 1cm lateral to the lateral canthus
and medially 3mm below the lower eyelash.at medial canthus incision
curves inferiorly into nasomaxillay groove down to alar margin.it
continues medially to the midline where it turns at right angle dividing
the upper lip.
-incision extends round the upper alveolus in the gingivobuccal sulcus
upto maxillary tuberosity.medially incision pass to hard palate between
the central incisors as far as junction of hard and soft palate,then
crosses laterally to the poserior aspect of maxillary tuberosity
2b. malignant nasal paranasal sinus ca.pptx
TECHNIQUE
• The entire soft tissue of cheek are raised subperiosteally off the
maxilla from the pyriform apperture to the zygomatic arch
including buccinator
• The orbicularis oculi left intact around the eye but the orbital
periosteum is incised at the bony rim allowing dissection of
orbital contents.infraorbital neurovascular bundle is cut at the
infra orbital foramen.
• Osteotomies are made through the zygoma beneath the
infraorbital rim,across the frontal process of maxilla,into
pyriform fossa,inferiorly through the central upper
alveolus.lateral nasal wall divided below the superior turbinate.
• Mobilization of maxilla completed by seperating the tuberosity
from the pterygoid plates.
2b. malignant nasal paranasal sinus ca.pptx
2b. malignant nasal paranasal sinus ca.pptx
• A variety of reconstructions are available.
• At its simplest,a split skin graft can be applied to the cavity
wall held in place with quilting incisions,biological glues,and
a temporary gutta percha prosthesis.
• Alternatively a free flap can be utilized, e.g. rectus abdominis,
latissimus dorsi, radial or fibula osteocutaneous flaps with
osseointegration
• Repairing lost orbital support decreases the risk of globe
malposition, diplopia and disturbance of extraocular muscle
function.
• Small defects in the floor can be left, larger ones can be
repaired using a fascia lata sling secured to the margins of
the bony defect
• Extensive spread of the tumour anteriorly into the
facial skin may necessitate sacrifice of this with repair
using a local pedicled or free microvascular flap.
• More frequently, extension occurs posteriorly into the
pterygoid region which adversely affects prognosis.
• Limited areas of pterygoid muscle can be removed.
• clearance of the pterygopalatine and infratemporal
fossae can be undertaken.
Reconstruction and Prosthetic Rehabilitation
Aim :
• - prevent contracture of the check
• -to separate oral & nasal cavities
• -to provide support for the globe .
• -An obturator should be made preoperatively
from an impression of the hard palate
2b. malignant nasal paranasal sinus ca.pptx
Tumours with bad prognosis
1- Advanced maxillary cancer .
2- lesions involving pterygoid plates or
pterygopalatine fossa .
3- lesions involving brain , dura , nasopharynx ,
sphenoid .
4- lesions involving orbital contents
Follow up
• 3 mths after Rx
- baseline physical examn
- CT, MRI or PET CT
• 1st
3 yrs – every 4 mths
• 4th
& 5th
yr – every 6 mths
• Then - annually

More Related Content

PPTX
malignant sinonasal tumors+management.pptx
PPTX
MALIGNANT TUMORS OF PARANASAL SINUSES
PPTX
Management of ca maxillary sinus
PPTX
Carcinoma Buccal Mucosa- Anatomy to Management
PPTX
LARYNGEAL CANCER MANAGEMENT
PPTX
Management of neck metastasis (1)
PPTX
Management of salivary gland tumor
PPTX
Paranasal sinuses carcinoma
malignant sinonasal tumors+management.pptx
MALIGNANT TUMORS OF PARANASAL SINUSES
Management of ca maxillary sinus
Carcinoma Buccal Mucosa- Anatomy to Management
LARYNGEAL CANCER MANAGEMENT
Management of neck metastasis (1)
Management of salivary gland tumor
Paranasal sinuses carcinoma

Similar to 2b. malignant nasal paranasal sinus ca.pptx (20)

PPTX
managementofsgtumor-170725185210.pptx
PPTX
Carcinoma nasopharynx
PPTX
Management of Oral Cavity Cancers
PPTX
Cancer of the Nasal Cavity and paranasal sinus .pptx
PPTX
head neck surgery : management of neck in oral carcinoma
PPTX
Trigeminal Schwannoma.pptx
PPTX
Ear carcinoma
PPTX
Nasopharyngeal carcinoma (NPC), previously known as lymphoepithelioma, is a m...
PPTX
Recent guidelines in management of oral and oropharyngeal carcinoma
PPT
Neoplasms of nose and pns
PPT
Neoplasms of nose and paranasal sinuses
PDF
Sino nasal malignancies
PPTX
TEMPORAL BONE TUMORS_SCOTT BROWN094144.pptx
PPTX
Sch.32 surgical management of parasagittal and convexity meningioma
PPTX
Sinonasal Tumours - Okoye
PPTX
Management Carcinoma Nose & PNS
PPTX
hypopharyngeal cancer description +anatomy+rt treatment
PPTX
DISEASES OF PAROTID GLAND in detail for PG
PPTX
Carcinoma larynx
PPTX
parapharyngeal space tumors
managementofsgtumor-170725185210.pptx
Carcinoma nasopharynx
Management of Oral Cavity Cancers
Cancer of the Nasal Cavity and paranasal sinus .pptx
head neck surgery : management of neck in oral carcinoma
Trigeminal Schwannoma.pptx
Ear carcinoma
Nasopharyngeal carcinoma (NPC), previously known as lymphoepithelioma, is a m...
Recent guidelines in management of oral and oropharyngeal carcinoma
Neoplasms of nose and pns
Neoplasms of nose and paranasal sinuses
Sino nasal malignancies
TEMPORAL BONE TUMORS_SCOTT BROWN094144.pptx
Sch.32 surgical management of parasagittal and convexity meningioma
Sinonasal Tumours - Okoye
Management Carcinoma Nose & PNS
hypopharyngeal cancer description +anatomy+rt treatment
DISEASES OF PAROTID GLAND in detail for PG
Carcinoma larynx
parapharyngeal space tumors
Ad

More from AlexGeor (20)

PPTX
instrumentation for fixed ortodontics(1).pptx
PPTX
Anchorage and dentofacial orthopedics.pptx
PPTX
head and neck Sarcoma-of-the-Jaw (1).pptx
PPTX
3. GIT physiology in oral and maxillofacial surgery ci.pptx
PPTX
2. salivary gland anatomy oral and maxillofacica.pptx
PDF
anatomyofperiodontium periodon-180923181101.pdf
PPTX
01 skin and skin lesions 1 dermatology coursepptx
PPTX
Epistaxis nasal bleeding undergraduate lecture
PPTX
disease of inner ear presentation for undergraduate
PPTX
Applied Anatomy and physiology of Ear.pptx
PPTX
the Anatomy and physiology of pharynx.pptx
PPTX
RL 2 CHapter 4. oral radiology lecture pptx
PPTX
chap-3j firearm injury maxillofacial.pptx
PPTX
chap-3c Wire and Wiring Techniques s.pptx
PPTX
chap-3j firearm injury maxillofacial.pptx
PPTX
chap-3c Wire and Wiring Techniques .pptx
PPTX
chap-3e Naso orbito ethmoid bone fracture OE fracture.pptx
PPTX
Zygomaticomaxillary complex Fracture pptx
PPTX
The Red Eye conjuctival diseases of the eyepptx
PPT
HISTORY AND PHYSICAL EXAM OF THE EYE. HO.ppt
instrumentation for fixed ortodontics(1).pptx
Anchorage and dentofacial orthopedics.pptx
head and neck Sarcoma-of-the-Jaw (1).pptx
3. GIT physiology in oral and maxillofacial surgery ci.pptx
2. salivary gland anatomy oral and maxillofacica.pptx
anatomyofperiodontium periodon-180923181101.pdf
01 skin and skin lesions 1 dermatology coursepptx
Epistaxis nasal bleeding undergraduate lecture
disease of inner ear presentation for undergraduate
Applied Anatomy and physiology of Ear.pptx
the Anatomy and physiology of pharynx.pptx
RL 2 CHapter 4. oral radiology lecture pptx
chap-3j firearm injury maxillofacial.pptx
chap-3c Wire and Wiring Techniques s.pptx
chap-3j firearm injury maxillofacial.pptx
chap-3c Wire and Wiring Techniques .pptx
chap-3e Naso orbito ethmoid bone fracture OE fracture.pptx
Zygomaticomaxillary complex Fracture pptx
The Red Eye conjuctival diseases of the eyepptx
HISTORY AND PHYSICAL EXAM OF THE EYE. HO.ppt
Ad

Recently uploaded (20)

PDF
11 Antiepileptic Drugs.pdf file for pharmacy
PPT
Medical Emergencies in Maxillofacial_Surgery.ppt
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
PPTX
Bronchial Asthma2025 GINA Guideline.pptx
PDF
FMCG-October-2021........................
PDF
Diabetes mellitus - AMBOSS.pdf
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PDF
Biochemistry And Nutrition For Bsc (Nursing).pdf
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPT
First Aid Training for construction and other
PPTX
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
DOCX
ORGAN SYSTEM DISORDERS Zoology Class Ass
PPTX
INFLAMMATORY BOWEL DISEASE(U,CERATIVE COLITIS AND CHROHN'S DISEASE)
PPTX
ENT-DISORDERS ( ent for nursing ). (1).p
PPTX
Nutrition needs in a Surgical Patient.pptx
PPTX
RESEARCH APPROACH & DESIGN.pptx presented by preeti kulshrestha
PPTX
Computed Tomography: Hardware and Instrumentation
PPTX
Ocular Drug Delivery Systems: Advances, Challenges, and Pharmaceutical Applic...
PDF
communicable diseases for healthcare - Part 1.pdf
PPTX
PSYCHIATRIC SEQUALAE OF HEAD INJURY.pptx
11 Antiepileptic Drugs.pdf file for pharmacy
Medical Emergencies in Maxillofacial_Surgery.ppt
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Bronchial Asthma2025 GINA Guideline.pptx
FMCG-October-2021........................
Diabetes mellitus - AMBOSS.pdf
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
Biochemistry And Nutrition For Bsc (Nursing).pdf
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
First Aid Training for construction and other
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
ORGAN SYSTEM DISORDERS Zoology Class Ass
INFLAMMATORY BOWEL DISEASE(U,CERATIVE COLITIS AND CHROHN'S DISEASE)
ENT-DISORDERS ( ent for nursing ). (1).p
Nutrition needs in a Surgical Patient.pptx
RESEARCH APPROACH & DESIGN.pptx presented by preeti kulshrestha
Computed Tomography: Hardware and Instrumentation
Ocular Drug Delivery Systems: Advances, Challenges, and Pharmaceutical Applic...
communicable diseases for healthcare - Part 1.pdf
PSYCHIATRIC SEQUALAE OF HEAD INJURY.pptx

2b. malignant nasal paranasal sinus ca.pptx

  • 2. Epidemiology • Maxillary sinus ca – 70% • Ethmoid(20%),frontal(3%),sphenoid(1%) sinus ca – extremely rare • 3% of head and neck malignacies • M > F ( 2 : 1 ) • Age – 6th & 7th decades • Carpenters, saw mill workers • Occupational exposure • Smoking • Alcohol
  • 3. Occupational agents correlated with sinonasal cancer
  • 4. Epithelial epidermoid Squamous cell carcinoma (spindlecell, verrucous, transitional Epithelial non- epidermoid Adenoid cystic carcinoma, Adenocarcinoma Mucoepidermoid carcinoma Acinic cell carcinoma neuroectodermal tumour Malignant melanoma, Olfactory neuroblastoma Neuroendocrine carcinoma Sinonasal undifferentiated carcinoma, Ewing’s sarcoma Odontogenic tumours Ameloblastoma Mesenchymal Fibrosarcoma, Liposarcoma Malignant fibrous histiocytoma Alveolar soft-part sarcoma Muscular Leiomyosarcoma, Rhabdomyosarcoma Vascular Angiosarcoma, Kaposi’s sarcoma Glomangiopericytoma (haemangiopericytoma) Cartilaginous Chondrosarcoma (mesenchymal) Osseous osteosarcoma Lymphoreticular Non-Hodgkin’s lymphoma, Burkitt’s lymphoma Extramedullary plasmacytoma T/NK lymphoma, Histiocytic/dendritic cell malignancies
  • 5. Squamous cell carcinoma • Squamous cell carcinoma remains the most common sinonasal malignancy • The majority probably arise in the maxillary sinus • Rarely the nasal septum or columella are the primary site. • These tumours have a particularly poor prognosis due to the possibility of bilateral metastatic spread to cervical nodes.
  • 6. ADENOCARCINOMA • Aout 30 per cent of patients with this condition are woodworkers. • These tumours usually arise in the middle meatus and spread into the ethmoid • Adenocarcinoma is generally rather radioresistant but combined therapy is usually offered. • Many patients require a craniofacial but in selected cases have been treated successfully by an endoscopic resection.
  • 7. Adenoid cystic carcinoma • Propensity to spread along perineural lymphatics which compromises attempts at excision. • known to produce blood-borne metastases, classically to the lung while lymphatic spread is rare. • Treatment is generally combined surgery and radiotherapy
  • 8. OLFACTORY NEUROBLASTOMA (OR) ESTHESIONEUROBLASTOMA • classically arises from olfactory epithelium in the upper nasal vault • The presence of a mass in the upper nasal cavity with associated skull base erosion is typical. • bimodal peak in the second/third and sixth/seventh decades. • Cervical metastases have been described in up to 23%. • These are routinely resected in craniofacial approaches • Endoscopic resection is being increasingly offered for this tumour particularly when it arises from the middle and superior turbinates. • should always be combined with radiotherapy.
  • 9. Ohngren's Line · Line running from medial canthus to angle of mandible · Prognosis of suprastructure tumors worse (This was before advent of craniofacial resection)
  • 10. Natural history & spread Maxillary ca
  • 11. Natural history & spread - contd Ethmoidal ca
  • 12. Natural history & spread – contd… Sphenoid sinus ca Frontal sinus ca
  • 13. Lymphatic Drainage • Usually sparse-10% incidence of cervical LNE • If tumor extension into skin of face, nasal cavity, NPX -> ↑ed incidence of LN->Assocated with poor prognosis • First echelon: submandibular nodes • Second echelon: subdigastric nodes - same side • Contralateral mets. extremely rare
  • 14. Clinical features Maxillary sinus ca • Facial swelling, pain, paresthesia of cheek • Epistaxis, nasal discharge, obstruction • Ill fitting dentures, alveolar/palatal mass • Proptosis, diplopia, impaired vision, orbital pain Ethmoid sinus ca • Headache • Referred pain to nasal, retrobulbar region • SC mass at inner canthus, nasal obstruction,discharge, diplopia & proptosis
  • 15. Work up • H & P • Routine blood examination • CXR- Adenocystic ca • CT/MRI • Dental evaluation • Baseline ophthalmologic examn • Baseline speech & swallowing assessment • Fiberoptic endoscopic examination & Bx
  • 16. Computed Tomography • Bone erosion – orbit, cribiform plate – fovea, post max sinus wall – sphenoid, post wall of frontal sinus • 85% accuracy • ? Tumor vs. inflammation vs. secretions • Limitation-periorbital involvement • CT Chest for Adenocystic ca
  • 17. MRI • Superior to CT - multiplanar - Detect intracranial, perineural & leptomeningeal spread • Inflammatory tissue & secretions - intense T2 • Tumor - intermediate T1 & T2 (low signal) • 94% accuracy • gadolinium (enhancement) 98% accuracy
  • 18. Primary tumor (T) Maxillary sinus: TX Primarytumorcannotbe assessed T0 No evidence ofprimarytumor Tis Carcinoma insitu T1 Tumor limited to maxillarysinus mucosa with noerosionordestructionofbone T2 Tumor causingbone erosionordestruction, includingextension into the hard palate and/or middlenasalmeatus, exceptextension to posteriorwallofthe maxillarysinus and pterygoidplates T3 Tumor invades anyofthe following:bone ofthe posteriorwallofthe maxillarysinus, subcutaneous tissues, flooror medial wallofthe orbit, pterygoid fossa, ethmoidsinuses T4a Moderatelyadvanced localdisease  Tumor invades theanteriororbitalcontents, skinofthe cheek, pterygoid plates, infratemporalfossa, cribriformplate, sphenoidorfrontalsinuses T4b Veryadvanced localdisease  Tumor invades anyofthe following: orbitalapex, dura, brain, middle cranialfossa, cranial nerves otherthan maxillarydivisionoftrigeminalnerve (V2), nasopharynx, orclivus
  • 19. AJCC- Nasal cavity & Ethmoid Sinus Tx - Primary tm cannot be assessed To - no evidence of primary tm Tis - carcinoma in situ T1 - Tm restricted to any one subsite with or without bony invasion T2 - invading two subsite in a single region or extending to involve an adjacent region within the nasoethmoidal complex T3 - invade medial wall/ floor of orbit, maxillary sinus,palate/ cribiform plate T4a - invade ant orbital contents, skin of nose /cheek, ant cranial fossa, pterygoid plates,sphenoid/ frontal sinus T4b - orbital apex, dura, brain,mid cranial fossa, cr nerves, nasopharynx/ clivus
  • 20. Staging – contd… Nx - regional nodal status cannot be assessed, No - No regional lymph node metastasis N1 - single I/L clinically +ve lymph node ≤ 3cm N2 - metastasis in ipsilateral, bilateral, contralateral node N2a - single I/L +ve LN >3cm <6cm N2b - multiple, I/L +ve LN <6cm N2c - B/L or C/L LN <6cm N3 - any LN > 6cm Mx - distant metastasis cannot be assessed Mo - No distant metastasis M1 -distant metastasis
  • 21. Staging – contd… Stagewise distribution stage I - T1N0M0 stage II – T2N0M0 stage III – T3N0M0 OR T1-T3N1M0 stage IV : - IVA -T4N0-1M0 any TN2 M0 - IVB any TN3M0 - IVC any T any N, M1
  • 22. Treatment options Maxillary sinus ca • Surgery • Radiotherapy - definitive - pre op RT - post op RT • Combined modality ( Sx + RT) • Chemotherapy - Neo adjuvant - Concomitant
  • 25. Surgery Contraindications - extension thr ant. Fossa - involvement of both optic n. - post. extension into sphenoid sinus - invasion of middle cranial fossa - extension into NPx - inoperable neck node & distant mets
  • 26. • CRANIOFACIAL RESECTION • MIDFACIAL DEGLOVING • LATERAL RHINOTOMY • MAXILLECTOMY • ENDOSCOPIC RESECTION • TOTAL RHINECTOMY
  • 27. Craniofacial resection • the ‘gold standard’ for tumours affecting the anterior skull base. CONTRAINDICATIONS • Extensive frontal lobe and/or middle cranial fossa involvement or bilateral orbital invasion/optic chiasm. • Certain histologies, such as mucosal malignant melanoma where extent of surgery does not influence outcome • those where surgery is not appropriate, such as sinonasal undifferentiated carcinoma, lymphoma, plasmacytoma. • Distant metastasis.
  • 28. INCISION • Following bilateral temporary tarsorrhaphies, an extended lateral rhinotomy is made on the side of maximal tumour involvement
  • 29. TECHNIQUE • The soft tissues of the face are mobilized by subperiostial elevation to expose the nasal bones, frontal processes of the maxilla and frontal bone up to the hairline via an extended lateral rhinotomy. • Through the lateral rhinotomy, the upper lateral cartilage is separated from the nasal bone to allow complete retraction of the nasal ala. • The orbital periosteum is elevated to expose the lacrimal fossa and the medial orbital wall. The nasolacrimal duct is often transacted obliquely at this point • anterior and posterior ethmoidal arteries are divided after bipolar coagulation. • If the lamina has been eroded by tumour, the adjacent periorbita should be resected for frozen section assessment
  • 30. • A shield-shaped craniotomy is performed above the level of the supraorbital rim to include the frontal sinus. usually approximately 3x3x3.5 cm size. • The frontal sinus which has been opened by this manoeuvre is cleared of its mucosa and the posterior wall removed combined with a wide dissection of the dura. • Dissection around the cribriform plate and crista galli is facilitated by the use of the operating microscope. • This dissection continues until the cribriform plate is exposed and continues on to the jugum of the sphenoid. • In cases of olfactory neuroblastoma routinely the olfactory bulb and tracts are removed in continuity. • The anterior and posterior ethmoidal arteries are coagulated with the bipolar diathermy although care must be exercised as the optic nerve is approached.
  • 33. • Osteotomies are performed around the cribriform plate through the ethmoidal and sphenoid roofs. • The posterior osteotomy crosses the planum sphenoidale to include the anterior face of the sphenoid and the nasal septum is separated by quadrilateral cuts. • The specimen is mobilized this can be removed, haemostasis achieved and the cavity inspected for further resection. • fashion a large middle meatal antrostomy to prevent subsequent infection. • dura has small defects which can be repaired primarily but more with fascia lata held in place with fibrin glue to which a split-skin graft taken from the thigh is applied inferiorly. • The frontal bone flap is replaced and secured with miniplates. • The periosteum and subcutaneous layer is closed with absorbable sutures and skin with clips or fine skin sutures. A pressure dressing is applied to both the head and leg.
  • 34. POST OP CARE • Patients are kept in a neutral position of approximately 15 degree for the first 2 or 3 days and then gently elevated. • The urinary catheter is removed on the second or third day and facial sutures after 5–7 days. • The anticonvulsant is continued for 6 weeks following the operation and patients must douche the nose long term.
  • 35. • Complications are: • IMMEDIATE: • – convulsions • – haemorrhage • – air embolism • INTERMEDIATE: • – cerebrovascular accident • – confusion • – pulmonary embolism • – meningitis • – aerocele • LONG TERM: • – haemorrhage • – frontal abscess/encephalitis • – bone necrosis/fistula • – cerebrospinal fluid leak • – epilepsy • – epiphora • – diplopia • – serous otitis media • – sinusitis/mucocele • – cellulitis • – pituitary deficiency
  • 36. MIDFACIAL DEGLOVING • The degloving approach affords excellent access to the middle third of the face. • Indicated in malignant tumours affecting the nasal cavity,maxilla,ethmoids,sphenoid, pterygopalatine and infratemporal fossae. INCISION • After temporary tarrsoraphies, a bilateral sublabial incision is made from maxillary tuberosity to tuberosity down to bone • Routine rhinoplasty intercartilaginous incisions are made extending into a transfixion incision along the dorsal and caudal borders of the cartilaginous septum,separating it from the medial crura of the lower lateral cartilages. • The circumferential incisions are joined across the floor of the nose just anterior to the pryriform aperture.
  • 38. • The soft tissues of the midface are elevated subperiosteally up to the infraorbital nerve on each side to display the pyriform aperture. • The soft tissues over the nasal bridge are elevated as far as the root of the nose and laterally to complete the mobilization from below so that the mid-third of the face is completely elevated and can be lifted superiorly over the nasal skeleton. • nasal cavities and maxillary sinuses can be opened using drills, hammers and osteotomes. • maxillary and sphenopalatine arteries accessed and ligated
  • 41. • ethmoids, sphenoid, nasopharynx and structures posterior and lateral to the maxillae are reached for further resection. • Closure of the incisions must be done with care to avoid complications, using absorbable suture material. • The bridge of the nose may be taped or a rhinoplasty dressing applied for a few days. • After pack removal patients advised to use saline douching daily until crusting settles.
  • 42. Lateral rhinotomy • Indicated in any malignant tumour affecting the nasal septum,lateral wall and extending into ethmoid, sphenoid, maxillary sinuses and up to the anterior skull base INCISION • After a temporary tarrsoraphy, the incision runs from the level of the medial canthus, midway between the canthus and nasal bridge in the nasomaxillary groove, curving round the lower ala into the nasal cavity
  • 43. TECHNIQUE • Through the incision, the orbital periosteum can be dissected from the lamina and the nasolacrimal duct mobilized.The duct can be transected obliquely adjacent to the sac. • Anterior and posterior ethmoidal arteries ligated • An en bloc or piecemeal removal of lateral nasal wall done including the pyriform aperture,nasal bone,frontal process of maxilla,anterior maxillary wall,medial orbital wall and rim,ethmoids lamina pipyracea and lacrymal fossa depending upon extend of tumour. • The sphenoid sinus can be opened,frontal can be accesed,orbital periosteum can be resected if required
  • 44. MAXILLECTOMY • Malignant tumors of maxilla involving all walls with/without orbital extension. INCISION -Weber-Fergusson incision extends 1cm lateral to the lateral canthus and medially 3mm below the lower eyelash.at medial canthus incision curves inferiorly into nasomaxillay groove down to alar margin.it continues medially to the midline where it turns at right angle dividing the upper lip. -incision extends round the upper alveolus in the gingivobuccal sulcus upto maxillary tuberosity.medially incision pass to hard palate between the central incisors as far as junction of hard and soft palate,then crosses laterally to the poserior aspect of maxillary tuberosity
  • 46. TECHNIQUE • The entire soft tissue of cheek are raised subperiosteally off the maxilla from the pyriform apperture to the zygomatic arch including buccinator • The orbicularis oculi left intact around the eye but the orbital periosteum is incised at the bony rim allowing dissection of orbital contents.infraorbital neurovascular bundle is cut at the infra orbital foramen. • Osteotomies are made through the zygoma beneath the infraorbital rim,across the frontal process of maxilla,into pyriform fossa,inferiorly through the central upper alveolus.lateral nasal wall divided below the superior turbinate. • Mobilization of maxilla completed by seperating the tuberosity from the pterygoid plates.
  • 49. • A variety of reconstructions are available. • At its simplest,a split skin graft can be applied to the cavity wall held in place with quilting incisions,biological glues,and a temporary gutta percha prosthesis. • Alternatively a free flap can be utilized, e.g. rectus abdominis, latissimus dorsi, radial or fibula osteocutaneous flaps with osseointegration • Repairing lost orbital support decreases the risk of globe malposition, diplopia and disturbance of extraocular muscle function. • Small defects in the floor can be left, larger ones can be repaired using a fascia lata sling secured to the margins of the bony defect
  • 50. • Extensive spread of the tumour anteriorly into the facial skin may necessitate sacrifice of this with repair using a local pedicled or free microvascular flap. • More frequently, extension occurs posteriorly into the pterygoid region which adversely affects prognosis. • Limited areas of pterygoid muscle can be removed. • clearance of the pterygopalatine and infratemporal fossae can be undertaken.
  • 51. Reconstruction and Prosthetic Rehabilitation Aim : • - prevent contracture of the check • -to separate oral & nasal cavities • -to provide support for the globe . • -An obturator should be made preoperatively from an impression of the hard palate
  • 53. Tumours with bad prognosis 1- Advanced maxillary cancer . 2- lesions involving pterygoid plates or pterygopalatine fossa . 3- lesions involving brain , dura , nasopharynx , sphenoid . 4- lesions involving orbital contents
  • 54. Follow up • 3 mths after Rx - baseline physical examn - CT, MRI or PET CT • 1st 3 yrs – every 4 mths • 4th & 5th yr – every 6 mths • Then - annually